Clinical trials
Junctional Epidermolysis Bullosa clinical trials
Below are recruiting junctional epidermolysis bullosa clinical trials, each written for real people, not researchers. We’re tracking 4 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06594393RecruitingPhase 2
Testing TCP-25 Gel for Epidermolysis Bullosa
This trial tests a gel called TCP-25 on wounds caused by a specific type of epidermolysis bullosa (DEB or JEB). It aims to see if the gel can help heal wounds and improve comfort.
Cincinnati, OhioAges 4 years+ - NCT03526159RecruitingPhase 1/Phase 2
Gentamicin treatment for certain skin blistering disease
This trial tests gentamicin, an antibiotic, for junctional epidermolysis bullosa (JEB) caused by a specific kind of genetic change in the LAMB3 gene. It may help some people with this exact mutation, but you must meet several safety and genetic requirements to join.
Los Angeles, CaliforniaAges Any age - NCT06423573Recruiting
Skin cancer risk in epidermolysis bullosa patients using Filsuvez
This study tracks anyone with dystrophic or junctional epidermolysis bullosa who is using Filsuvez gel to see how often skin cancers appear. It is designed to understand the long-term safety of the treatment.
ToulouseAges Any age - NCT06917690RecruitingPhase 3
Testing oleogel-S10 for epidermolysis bullosa in Japanese patients
This trial tests a gel called oleogel-S10 on wounds caused by a rare skin condition called epidermolysis bullosa (EB). It is only for people of Japanese descent who have a specific type of EB called junctional or dystrophic EB. The gel is put on the wound to help it heal.
FukuokaAges 3 weeks+
Hear when a new Junctional Epidermolysis Bullosa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for junctional epidermolysis bullosa?
- Yes. Clin2 currently lists 4 recruiting junctional epidermolysis bullosa studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a junctional epidermolysis bullosa trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a junctional epidermolysis bullosa trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.